{"entity":{"type":"insider","cik":"0001600164","url":"/insider/0001600164","json_url":"/insider/0001600164.json","name":"MacKenzie Lloyd","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":2,"n_filings":2,"first":"2015-08-14","last":"2018-03-19","span_basis":"filed_date"},"name_variants":[{"name":"MacKenzie Lloyd","source":"filing","n_filings":2,"first_seen":"2015-08-14","last_seen":"2018-03-19"}],"transactions":[{"id":6797401,"accession":"0001209191-18-020680","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-020680","line_url":"/filing/0001209191-18-020680#line-2","is_derivative":false,"issuer_cik":"0001404644","issuer_name":"AQUINOX PHARMACEUTICALS, INC","issuer_ticker":"AQXP","issuer_name_source":null,"issuer_url":"/issuer/0001404644","owner_cik":"0001600164","owner_name":"MacKenzie Lloyd","owner_display_name":"MacKenzie Lloyd","owner_url":"/insider/0001600164","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1302.0,"shares_display":"1,302","price_per_share":14.6304,"price_display":"14.63","price_state":"stated","total_value":19048.7808,"total_display":"19,048.78","total_whole":"19,049","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-15","filed_date":"2018-03-19","scope":"insider"},{"id":8603863,"accession":"0001209191-15-066178","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-066178","line_url":"/filing/0001209191-15-066178#line-3","is_derivative":false,"issuer_cik":"0001404644","issuer_name":"AQUINOX PHARMACEUTICALS, INC","issuer_ticker":"AQXP","issuer_name_source":null,"issuer_url":"/issuer/0001404644","owner_cik":"0001600164","owner_name":"MacKenzie Lloyd","owner_display_name":"MacKenzie Lloyd","owner_url":"/insider/0001600164","role":"Officer (VP Technical Operations)","role_mark":"O","role_mark_label":"Officer (VP Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35887.0,"shares_display":"35,887","price_per_share":18.67,"price_display":"18.67","price_state":"stated","total_value":670010.29,"total_display":"670,010.29","total_whole":"670,010","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-12","filed_date":"2015-08-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":2,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":2},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001404644","name":"AQUINOX PHARMACEUTICALS, INC","url":"/issuer/0001404644","role":"Officer (Chief Operating Officer)","n_filings":2,"first_seen":"2015-08-14","last_seen":"2018-03-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001600164","retrieved_at":"2026-08-26T01:52:48+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}